The cost-effectiveness of strategies in coronary artery disease

Nenhuma Miniatura disponível
Citações na Scopus
4
Tipo de produção
article
Data de publicação
2014
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
EXPERT REVIEWS
Autores
Citação
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, v.14, n.6, p.805-813, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Coronary artery disease has significant social and economic implications. Health expenditures have increased in recent decades, more than the economy itself, with significant consequences, either reducing spending in other areas or increasing the budget deficit. It is necessary to create tools to identify the most cost-effective treatments, which can assist clinicians in their therapeutic decisions so that the maximum possible benefit is reached with the lowest possible cost. Efficiency must be measured by final treatment goals in which the most effective interventions are those with the lowest costs. We analyzed the cost-effectiveness of coronary artery disease treatment strategies, medical treatment, percutaneous coronary intervention and coronary artery bypass surgery, with a focus on comparative analyses between these treatment modalities.
Palavras-chave
coronary artery bypass graft, coronary artery disease, cost-effectiveness, myocardial ischemia, percutaneous coronary intervention
URI
https://observatorio.fm.usp.br/handle/OPI/8923
Referências
  1. Abizaid A, 2001, CIRCULATION, V104, P533, DOI 10.1161/hc3101.093700
  2. Bakhai A, 2006, J AM COLL CARDIOL, V48, P253, DOI 10.1016/j.jacc.2006.02.063
  3. Bell CM, 2006, BRIT MED J, V332, P699, DOI 10.1136/bmj.38737.607558.80
  4. Bischof M, 2009, VALUE HEALTH, V12, P649, DOI 10.1111/j.1524-4733.2009.00513.x
  5. Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829
  6. Chan PS, 2007, CIRCULATION, V115, P2398, DOI 10.1161/CIRCULATIONAHA.106.667683
  7. Chen J, 2009, VALUE HEALTH, V12, P872, DOI 10.1111/j.1524-4733.2009.00529.x
  8. Claude J, 2004, EUR HEART J, V25, P2195, DOI 10.1016/j.ehj.2004.09.013
  9. Cohen DJ, 2004, CIRCULATION, V110, P508, DOI 10.1161/01.CIR.0000136821.99814.43
  10. Cohen DJ, 2012, CATHETER CARDIO INTE, V79, P198, DOI 10.1002/ccd.23147
  11. De Bruyne B, 2012, NEW ENGL J MED, V367, P991, DOI 10.1056/NEJMoa1205361
  12. Dulisse B, 2005, AM HEART ASS SCI SES
  13. Durand-Zaleski I, 2004, PHARMACOECONOMICS, V22, P19, DOI 10.2165/00019053-200422004-00005
  14. Eisenberg MJ, 2006, CIRCULATION, V114, P1745, DOI 10.1161/CIRCULATIONAHA.106.646190
  15. European Heart Network, EUR CARD DIS STAT 20
  16. Farkouh ME, 2012, NEW ENGL J MED, V367, P2375, DOI 10.1056/NEJMoa1211585
  17. Favarato D, 2003, CIRCULATION, V108, P21, DOI 10.1161/01.cir.0000087381.98299.7b
  18. Fearon WF, 2013, CIRCULATION, V128, P1335, DOI 10.1161/CIRCULATIONAHA.113.003059
  19. Filion KB, 2009, AM J CARDIOL, V103, P338, DOI 10.1016/j.amjcard.2008.09.086
  20. Girardi PBMA, 2008, ARQ BRAS CARDIOL, V91, P340
  21. Go AS, 2014, CIRCULATION, V129, P28
  22. Hlatky MA, 2006, CLIN TRIALS, V3, P543, DOI 10.1177/1740774506073105
  23. Hlatky MA, 2009, CIRCULATION, V120, P2550, DOI 10.1161/CIRCULATIONAHA.109.912709
  24. Hlatky MA, 1997, NEW ENGL J MED, V336, P92, DOI 10.1056/NEJM199701093360203
  25. Hueb W, 2007, CIRCULATION, V115, P1082, DOI 10.1161/CIRCULATIONAHA.106.625475
  26. Kamalesh M, 2013, J AM COLL CARDIOL, V61, P808, DOI 10.1016/j.jacc.2012.11.044
  27. Kapur A, 2010, J AM COLL CARDIOL, V55, P432, DOI 10.1016/j.jacc.2009.10.014
  28. Karnon J, 2005, CURR MED RES OPIN, V21, P101, DOI 10.1185/030079904X18036
  29. Kastanioti C, 2007, Eur J Cardiovasc Nurs, V6, P54, DOI 10.1016/j.ejcnurse.2006.04.001
  30. Kourlaba Georgia, 2012, Appl Health Econ Health Policy, V10, P331, DOI 10.2165/11633970-000000000-00000
  31. Krenn L, 2014, CATHETER CARDIOVASC
  32. Lindgren P, 2007, EUR HEART J, V28, P1448, DOI 10.1093/eurheartj/ehm020
  33. Longman JF, 2010, APPL HLTH EC HLTH PO, V8, P251
  34. Magnuson EA, 2013, CIRCULATION, V127, P820, DOI 10.1161/CIRCULATIONAHA.112.147488
  35. Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437
  36. Rinfret Stéphane, 2006, Am J Cardiovasc Drugs, V6, P159, DOI 10.2165/00129784-200606030-00003
  37. Schleinitz MD, 2004, AM J MED, V116, P797, DOI 10.1016/j.amjmed.2004.01.014
  38. Serruys PW, 2001, NEW ENGL J MED, V344, P1117, DOI 10.1056/NEJM200104123441502
  39. Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626
  40. Serruys PW, 2005, J AM COLL CARDIOL, V46, P575, DOI 10.1016/j.jacc.2004.12.082
  41. Shrive FM, 2005, CAN MED ASSOC J, V172, P345, DOI 10.1503/cmaj.1041062
  42. Siebert U, 2014, HEART LUNG CIRC, V23, P527, DOI 10.1016/j.hlc.2013.12.009
  43. Sigwart U, 2002, LANCET, V360, P965
  44. Stroupe KT, 2006, CIRCULATION, V114, P1251, DOI 10.1161/CIRCULATIONAHA.105.570838
  45. Alderman EL, 1996, NEW ENGL J MED, V335, P217
  46. Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611
  47. Vieira RD, 2012, CIRCULATION S1, V126, P145
  48. Wagner M, 2009, CAN J CARDIOL, V25, P362
  49. Wagner TH, 2013, ANN THORAC SURG, V96, P770, DOI 10.1016/j.athoracsur.2013.04.074
  50. Weintraub WS, 2012, NEW ENGL J MED, V366, P1467, DOI 10.1056/NEJMoa1110717
  51. Weintraub WS, 2008, CIRC-CARDIOVASC QUAL, V1, P12, DOI 10.1161/CIRCOUTCOMES.108.798462

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCP
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/11
Artigos e Materiais de Revistas Científicas - ODS/03